BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23151447)

  • 1. Plasmid IL-12 electroporation in melanoma.
    Cha E; Daud A
    Hum Vaccin Immunother; 2012 Nov; 8(11):1734-8. PubMed ID: 23151447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
    Daud AI; DeConti RC; Andrews S; Urbas P; Riker AI; Sondak VK; Munster PN; Sullivan DM; Ugen KE; Messina JL; Heller R
    J Clin Oncol; 2008 Dec; 26(36):5896-903. PubMed ID: 19029422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).
    Canton DA; Shirley S; Wright J; Connolly R; Burkart C; Mukhopadhyay A; Twitty C; Qattan KE; Campbell JS; Le MH; Pierce RH; Gargosky S; Daud A; Algazi A
    Immunotherapy; 2017 Dec; 9(16):1309-1321. PubMed ID: 29064334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
    Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
    Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses.
    Greaney SK; Algazi AP; Tsai KK; Takamura KT; Chen L; Twitty CG; Zhang L; Paciorek A; Pierce RH; Le MH; Daud AI; Fong L
    Cancer Immunol Res; 2020 Feb; 8(2):246-254. PubMed ID: 31852717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
    Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
    Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
    Lucas ML; Heller R
    DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation gene therapy preclinical and clinical trials for melanoma.
    Heller LC; Heller R
    Curr Gene Ther; 2010 Aug; 10(4):312-7. PubMed ID: 20557286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity.
    Han M; Nguyen B; Lee JY; Browning E; Zhang J; Mukhopadhyay A; Gujar R; Salazar J; Hermiz R; Svenson L; Rolig AS; Redmond WL; Algazi AP; Daud AI; Canton DA; Twitty CG
    Mol Cancer Res; 2022 Jun; 20(6):983-995. PubMed ID: 35302641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.
    Algazi A; Bhatia S; Agarwala S; Molina M; Lewis K; Faries M; Fong L; Levine LP; Franco M; Oglesby A; Ballesteros-Merino C; Bifulco CB; Fox BA; Bannavong D; Talia R; Browning E; Le MH; Pierce RH; Gargosky S; Tsai KK; Twitty C; Daud AI
    Ann Oncol; 2020 Apr; 31(4):532-540. PubMed ID: 32147213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.
    Kim H; Sin JI
    Hum Vaccin Immunother; 2012 Nov; 8(11):1714-21. PubMed ID: 23151450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
    Lucas ML; Heller L; Coppola D; Heller R
    Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
    Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
    Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
    Li S; Xia X; Mellieon FM; Liu J; Steele S
    Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical investigation of the synergy effect of interleukin-12 gene-electro-transfer during partially irreversible electropermeabilization against melanoma.
    Pasquet L; Bellard E; Chabot S; Markelc B; Rols MP; Teissie J; Golzio M
    J Immunother Cancer; 2019 Jun; 7(1):161. PubMed ID: 31242938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.
    Kamensek U; Cemazar M; Lampreht Tratar U; Ursic K; Sersa G
    Cancer Immunol Immunother; 2018 May; 67(5):785-795. PubMed ID: 29468364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.
    Shah K; Connolly RJ; Chapman T; Jaroszeski MJ; Ugen KE
    Hum Vaccin Immunother; 2012 Nov; 8(11):1722-8. PubMed ID: 23151446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model.
    Heller L; Merkler K; Westover J; Cruz Y; Coppola D; Benson K; Daud A; Heller R
    Clin Cancer Res; 2006 May; 12(10):3177-83. PubMed ID: 16707618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.